載入...
Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
BACKGROUND: Recent large-scale clinical trials have shown that SGLT2-inhibitors reduce cardiovascular events in diabetic patients. However, the regulation and functional role of cardiac sodium–glucose cotransporter (SGLT1 is the dominant isoform) compared with those of other glucose transporters (in...
Na minha lista:
| 發表在: | Cardiovasc Diabetol |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6604374/ https://ncbi.nlm.nih.gov/pubmed/31262297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0889-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|